期刊
SAUDI PHARMACEUTICAL JOURNAL
卷 28, 期 4, 页码 409-413出版社
ELSEVIER
DOI: 10.1016/j.jsps.2020.02.001
关键词
Zanthoxylum flavum; Rutaceae; Sesamin; Monoamine oxidase inhibition; Antimicrobial; Antiprotozoal
资金
- Egyptian Government
- University of Mississippi
- National Center for Natural Products Research, the United States
- NIH COBRE grant [P20GM104932]
Monoamine oxidase inhibition is an important therapeutic approach for various neurodegenerative disorders. Reversible MAO inhibitors selectively targeting only one isoform possess substantial merit in terms of safety, efficacy, and side effect profile. This study aimed to isolate the secondary metabolites of Zanthoxylum flavum stems and evaluate their recombinant human MAO inhibition, antimicrobial, and antiprotozoal activities. As a result, fourteen compounds were isolated and identified (nine of them were reported from Z. flavum for the first time). Compound 3 (sesamin) exhibited potent selective MAO-B inhibition (IC50 value of 1.45 +/- 0.05 mM) which reported herein for the first time. Compound 2 showed selective MAO-A inhibition activity, compound 5 exhibited good trypanocidal activity, and compound 7 displayed moderate antibacterial activity. The promising MAO-B inhibitory activity of sesamin provoked us to further explore the kinetic properties, the binding mode, and the underlying mechanism of MAO-B inhibition by this lignan. This detailed investigation substantiated a reversible binding and mixed MAO-B catalytic function inhibition via sesamin (K-i: 0.473 +/- 0.076 mu M). Selectivity and reversibility of sesamin on MAO-B provide exciting prerequisites for further in vivo investigation to confirm its therapeutic potentiality. (C) 2020 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据